Skip to content

Acute Graft Versus Host Disease C0856825

Published: July 22, 2026Updated: August 27, 2026

A complication after bone marrow transplant where donor cells attack the recipient's body. Treated with immunosuppressive medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Jaundice

!

Severe skin bullae

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Maculopapular skin rash

(integumentary)

Diarrhea

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corticosteroid therapy

High-dose systemic corticosteroids are the cornerstone of acute GvHD management, suppressing the donor immune response that targets host tissues. Treatment is typically initiated promptly upon diagnosis to prevent progression to severe manifestations.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Calcineurin inhibitor therapy

Calcineurin inhibitors such as tacrolimus or cyclosporine inhibit T-cell activation, reducing graft-versus-host immune responses. These agents require therapeutic drug monitoring due to narrow therapeutic windows and significant drug interactions.

medication

Additional treatment options

Extracorporeal photopheresis

This procedure involves collecting white blood cells, treating them with photoactive agents and UV light, then returning them to the patient to modulate immune function. It is particularly useful for steroid-refractory cases.

procedure

Infection surveillance

Intensive monitoring for opportunistic infections including fungal, viral, and bacterial pathogens given immunosuppressed state. Regular surveillance cultures and imaging help detect early infections.

monitoring

Nutritional support therapy

Enteral or parenteral nutrition to maintain adequate caloric intake and protein balance during acute illness. Prevents malnutrition that can compromise immune recovery and wound healing.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Graft Versus Host Disease C0856825?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ferrara JL, Levine JE. National Comprehensive Cancer Network Clinical Practice Guidelines for Graft-versus-Host Disease. Bone Marrow Transplant. 2022.

guideline2022
2

MacMillan ML, DeFor TE, Hipkins KL. A Phase II Trial of Extracorporeal Photopheresis for Acute Graft-versus-Host Disease. Blood Adv. 2021.

clinical_trial2021
3

Garnett C, Apperley JF, Pavlů J. Diagnosis and Management of Acute Graft-versus-Host Disease. Br J Haematol. 2020.

review2020
4

Hatakeyama N, Hiwatari K, Kajimoto H. Ruxolitinib for Steroid-Refractory Acute GVHD: A Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Acute Graft Versus Host Disease C0856825. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy